DurgicalDurgical
EN
Open the app

Biochemistry · Metabolic pathway

Lysosomal ganglioside breakdown !

Lysosomes take gangliosides apart one piece at a time, down to sphingosine. A missing enzyme at any step causes a storage disease.

Updated 2026-11-01

Interactive map

Key facts

  • Each step removes the outermost sugar (or, at the end, the fatty acid) and needs the step before it: the order is strict.
  • GM2 → GM3 needs hexosaminidase A plus the GM2 activator protein; their loss causes Tay–Sachs disease and its variants.
  • Glucocerebrosidase turns glucosylceramide into ceramide; its deficiency, Gaucher disease, is the most common lysosomal storage disease.
  • Acid ceramidase deficiency (Farber disease) gives a hoarse cry, painful swollen joints and nodules under the skin.
  • Saposins (sphingolipid activator proteins) help most of these hydrolases reach their lipid substrates.
Also called
Sphingolipid degradation

Regulation

  • These enzymes are not under hormonal control; flux depends on how much lipid arrives by endocytosis and autophagy.
  • The transcription factor TFEB raises the whole set of lysosomal enzymes when lysosomes are under stress.
  • Mannose-6-phosphate tags send the enzymes to the lysosome; without them (I-cell disease) all are missing from it.

The steps, one by one

  1. Step 1 · Acid β-galactosidase (GLB1) irreversible GM1 ganglioside + H₂O → gm2_ganglioside + GalactoseRemoves the terminal galactose of GM1, leaving GM2.If it fails: GM1 gangliosidosis: neurodegeneration, cherry-red spot, enlarged liver and spleen and bone changes in the infantile form. GM1 gangliosidosis →
  2. Step 2 · β-Hexosaminidase A (HEXA α + HEXB β subunits) with the GM2 activator irreversible gm2_ganglioside + H₂O → GM3 ganglioside + N-AcetylgalactosamineCuts off N-acetylgalactosamine; only the αβ form (Hex A), helped by the GM2 activator protein, can reach GM2.If it fails: Tay–Sachs (HEXA): GM2 fills neurons, with a cherry-red spot and no organ enlargement; Sandhoff (HEXB) also loses Hex B and adds visceral signs. Tay–Sachs disease →
  3. Step 3 · Lysosomal sialidase (neuraminidase; NEU1, NEU4) irreversible GM3 ganglioside + H₂O → Lactosylceramide + Sialic acid (NANA)Removes the sialic acid (N-acetylneuraminic acid) that makes a lipid a ganglioside, leaving the neutral lactosylceramide.If it fails: NEU1 deficiency causes sialidosis, with cherry-red spot and myoclonus; it mainly stores sialylated glycoproteins rather than GM3.
  4. Step 4 · β-Galactosidase (galactocerebrosidase GALC or GLB1) with saposins irreversible Lactosylceramide + H₂O → Glucosylceramide + GalactoseRemoves galactose from lactosylceramide, leaving glucosylceramide; galactocerebrosidase and GM1 β-galactosidase can both do it.If it fails: Fabry disease joins here: without α-galactosidase A, globotriaosylceramide cannot be trimmed to lactosylceramide and builds up in vessels, kidney and heart. Fabry disease →
  5. Step 5 · Glucocerebrosidase (acid β-glucosidase, GBA1) irreversible Glucosylceramide + H₂O → Ceramide + GlucoseRemoves the glucose from glucosylceramide, with help from saposin C, leaving ceramide.If it fails: Gaucher disease: glucosylceramide fills macrophages (Gaucher cells) in spleen, liver and bone marrow; GBA1 variants also raise the risk of Parkinson disease. Gaucher disease →
  6. Step 6 · Acid ceramidase (ASAH1) irreversible Ceramide + H₂O → Sphingosine + Fatty acidSplits the amide bond of ceramide into sphingosine and a fatty acid, which leave the lysosome to be reused.If it fails: Farber disease: ceramide builds up in joints, larynx and skin, with nodules, swollen joints and a hoarse cry. Ceramide also arrives from sphingomyelin (Niemann–Pick), galactosylceramide (Krabbe) and sulfatide (metachromatic leukodystrophy). Farber disease (Farber lipogranulomatosis) →

Clinical notes

  • Cherry-red spot in the macula: Tay–Sachs, Sandhoff, GM1 gangliosidosis and Niemann–Pick type A.
  • Enzyme replacement exists for Gaucher and Fabry disease; substrate reduction (eliglustat, miglustat) slows glucosylceramide synthesis.
  • Side branches join this line: Fabry (α-galactosidase A), Krabbe (galactocerebrosidase), metachromatic leukodystrophy (arylsulfatase A) and Niemann–Pick (sphingomyelinase).
  • Most are autosomal recessive; Fabry disease is X-linked.

Pathways

Test yourself

Think of the answer, then tap the question to see it.

Which enzyme is missing in Tay–Sachs disease, and which lipid accumulates?

Hexosaminidase A (HEXA gene); GM2 ganglioside accumulates in neurons.

Which step fails in Gaucher disease?

Glucocerebrosidase cannot turn glucosylceramide into ceramide, so glucosylceramide fills macrophages.

What are the three classic signs of Farber disease?

A hoarse voice or weak cry, nodules under the skin (lipogranulomas) and painful swollen joints, from ceramide build-up.

Which lysosomal disease of this pathway is X-linked?

Fabry disease (α-galactosidase A); the others in this pathway are autosomal recessive.

Add to my cards (4)

Educational information, not medical advice. For any symptom, see a health professional.

Sources: Tay-Sachs disease: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Gaucher disease: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Farber lipogranulomatosis: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); GM1 gangliosidosis: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Sialidosis: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Textbook of Biochemistry for Medical Students, 6th ed. (Jaypee Brothers Medical Publishers (Vasudevan DM, Sreekumari S, Vaidyanathan K), 2011).

← All of biochemistry

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.